Good ON Time

Advertisement

cGxPJobs Banner

Teva Bids for BioXcel’s BXCL501 in Potential At-Home Agitation Treatment Deal

Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...

By cGxPwire Editor
August 31, 2026

Read More

Zambon Announces European Commission Approval of Hopledo for Parkinson’s Disease Motor Fluctuations

Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...

By cGxPwire Editor
August 31, 2026

Read More

Advertisement

cGxPJobs

Directory